Neuroone Medical Technologies is trading 6.5% down at $2.02 as the stock faces continued pressure following missed Q2 earnings and ongoing concerns regarding its status as a cash-burning micro-cap.
- The move follows a period of volatility for small-cap medical device names, with the stock recently hitting 52-week lows.
- Despite broader markets trading higher, sentiment remains cautious with no new company-specific filings or news released today to offset the downward trend.